(2026). Correction to: Long-term safety analysis of pooled data for tislelizumab as monotherapy or in combination with chemotherapy in patients with advanced cancers. The Oncologist.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Correction to: Long-term Safety Analysis of Pooled Data for Tislelizumab as Monotherapy or in Combination with Chemotherapy in Patients with Advanced Cancers."
The Oncologist 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Correction to: Long-term Safety Analysis of Pooled Data for Tislelizumab as Monotherapy or in Combination with Chemotherapy in Patients with Advanced Cancers."
The Oncologist, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.